AbbVie (ABBV) Stock Concentration Calculator
Calculator · free · no signup · ABBVQuantify AbbVie concentration risk. Drawdown impact at 30 / 50 / 70%, with the tax-aware trade-off between selling down and hedging.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
Your inputs
Adjust — results update instantly.Position & portfolio
Tax
Most fee-only advisors target ≤10% in any single name. You're at 67%.
Estimates only. Not financial advice.
Most sensitive to: Expected market return (±10% on this input swings best-plan wealth by ±$190,508).
Cost of fully de-concentrating
All three plans sell to 0% (no hedge).Sensitivity. If your expected position return drops below 19.6%/yr, lump-sum (sell everything today) beats every spread plan above.
Have multiple RSU vest lots? The RSU Lot Order Calculator picks which lots to sell first, and on which dates, to divest at the lowest computed tax.
Build your own plan
Toggle below — chart updates live. Sell buttons show the slice.Tech / Software single names hit a 50%+ peak-to-trough drawdown in roughly 1 of every 5 rolling 3-year windows over 2014–2024. Even mega-caps aren’t exempt.
Tax brackets: 2026 · Estimates only — not financial advice.
Estate note. Heirs receive a stepped-up basis at death (§1014), eliminating built-in gain on inherited shares. Older holders who plan to bequeath rather than sell may rationally never de-concentrate.
You sized one position's risk. The beta integrates hedging, sell-down, and tax timing into one optimized plan.
Request beta access →Related calculators: Protect Your Stock Calculator · RSU Lot Order Calculator · Equity Funding Plan Calculator
About AbbVie
AbbVie (ABBV) is a public Pharma/Biotech company, incorporated in Delaware and headquartered in North Chicago, IL.
Last close: $261.59 per share (as of 2026-10-01).
Equity grants at AbbVie typically include restricted stock units (RSUs).
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Source: Wikipedia (CC BY-SA 4.0)
AbbVie separated from Abbott Laboratories on January 1, 2013, becoming an independent, publicly traded research-based pharmaceutical company headquartered in North Chicago, Illinois. It develops and markets prescription medicines in immunology (Skyrizi, Rinvoq), oncology, neuroscience, and aesthetics, the last added through its 2020 acquisition of Allergan (maker of Botox Cosmetic). The company employs roughly 55,000 people worldwide and grants equity compensation, including RSUs (restricted stock units, shares that vest over time) and stock options, as part of employee pay. AbbVie reported record full-year 2025 net revenue of $61.2 billion, up 8.5% operationally, with immunology products contributing $30.4 billion of that total.
Sources: sec.gov · investors.abbvie.com · en.wikipedia.org
Equity comp at AbbVie
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Researched 2026-08-17.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by AbbVie.
If a meaningful share of your net worth sits in ABBV, concentration risk is the question. This calculator quantifies drawdown impact at 30 / 50 / 70%, and the trade-off between selling down (tax cost now) versus hedging (option premium drag), auto-filled with ABBV's option-implied volatility.
Example: 5,000 ABBV shares at $261.59 is a $1,307,950 position. A 30% drawdown costs $392,385; a 50% drawdown costs $653,975; a 70% drawdown costs $915,565. The calculator quantifies the trade-off between selling down (immediate capital-gains tax) and hedging (option premium drag) using ABBV's option-implied volatility and your cost basis.
All AbbVie tools → · Use the generic Stock Concentration Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →
AbbVie equity questions
- How much ABBV stock is too much?
- There is no single threshold, but the larger the share of your net worth in one stock, the more a single bad year can set back your plans. The calculator above quantifies the drawdown impact at 30, 50, and 70 percent for your ABBV position and weighs selling down (which triggers capital-gains tax now) against hedging (which costs option premium).
- Does AbbVie grant ISOs, NSOs, or RSUs?
- Equity compensation at AbbVie typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do AbbVie RSUs use double-trigger vesting?
- No. AbbVie restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your AbbVie equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.